Participated · Equity · Jul 2025

Blue Longevity Clinic provides a fully integrated approach to healthy ageing, combining in-person functional diagnostics, lifestyle medicine, regenerative therapies, and personalised therapy programs. The company pairs comprehensive biomarker testing (metabolic, brain, gut, genetic) with expert clinicians who create tailored health protocols and in-house therapies. It also offers a white-labeled digital app that supports microhabit formation and AI-assisted longevity reports reviewed by physicians to track and optimise cardiovascular, metabolic, genetic, and mental health. Blue Longevity emphasizes a vertically integrated, high-touch model designed to drive strong patient retention and broaden access beyond exclusive physician-led clinics. The team is investing in further development of its digital app and an AI diagnostics engine to personalise and scale the client experience. The newly raised capital will support clinic build-outs, completion of therapy protocols, medical team expansion, and growth of the company’s proprietary technology platform.

Participated · Equity · Sep 2024

Ogre AI is a Bucharest-based company that provides AI solutions for the energy sector, specializing in advanced forecasting tools. Its flagship product, the Ogre forecasting system, uses machine learning to predict energy generation and demand and to manage variability from solar and wind power. The company focuses on reducing the uncertainty of renewable energy output and fluctuations in energy demand. In September 2024 it raised €3.0M in a funding round led by VERBUND X Ventures with participation from Early Game Ventures, Soulmates Ventures, MMC VC Fund, and Sofia Angels Ventures. The funding will be used to expand the company's technology and market presence. VERBUND X Ventures is the corporate venture arm of Austria's main electricity supplier and invests in early-stage renewable energy companies across Europe. Ogre AI develops ML- and AI-driven forecasting and anomaly-detection products for the energy industry, predicting generation, consumption, technological and commercial losses, and system anomalies. Its solutions have been implemented at major utilities including Enel, CEZ, Engie, PPC, DEER and E.ON. The company says its products have helped customers reduce financial losses by up to 30% caused by inadequate forecasting tools. Ogre AI is preparing for a new funding round and aims to become a leading provider of analysis and forecasting solutions for the energy market. The startup anticipates reaching revenues of one million dollars in 2024. Ogre AI is headquartered in London with offices in Bucharest and Athens, and was founded and is led by Matei Stratan (CEO) alongside co‑founders Mihai Cucuringu (CRO) and Paul Muscă (CTO). SC Ogre Artificial Intelligence SRL (Ogre AI) is a Romanian data‑science startup offering an AI platform for energy management that uses machine learning to support financial and operational decision‑making. Its software helps partners forecast generation and consumption and detect network/grid technical and commercial losses and anomalies. Ogre AI works with energy and utility companies to integrate forecasting and anomaly detection into operations. The team is developing an innovative price‑forecast system intended to aid grid management and trading decisions. The company emphasizes that data science and AI are shaping the future of the energy industry. In February 2022 Ogre AI completed a €2.0M seed funding round, reflecting early-stage external validation of its product and market approach.

Led · Equity · Jul 2024

Ethermind builds an AI assistant that enhances the learning experience during corporate training and professional upskilling, answering participants' questions from logistics to complex concepts. Its technology aims to keep trainings at the right pace and make self-study sessions interactive. The company plans to accelerate development of Ethermind Copilot and scale its solutions across corporate and educational sectors. Ethermind emphasizes personalized, continuous, and adaptive learning to address inefficiencies, high costs, and lack of customization in traditional training. Financially, Ethermind has secured over half a million pounds in initial funding led by Sofia Angels Ventures with participation from private and angel investors. The company was recognized as one of the Top AI in Training Companies for 2024, is a member of the Microsoft for Startups Founders Hub, and was a finalist in the EdTechX 2024 Awards.

Led · Equity · Jun 2024

Denxpert is an EHS & Sustainability and ESG management consulting and Software as a Service provider offering a one-stop shop to manage EHS&S legislation, obligations, and optimized processes. Its platform and services aim to enable swift and hassle-free compliance and operational workflows for customers. The company serves over 500 companies worldwide, including clients such as MOL, Telekom, Mercedes, E.On, Vantage DC, Rauch, PPF, and Vienna Airport. In June 2024 Denxpert raised €1.0M to support its growth. The company plans to use the funding to scale and expand operations internationally. Denxpert’s fundraising and roadmap are positioned to address growing demand for detailed and transparent sustainability data driven by new EU CSRD regulations.

Participated · Equity · May 2024

Inheart develops an AI-driven digital twin of the heart as a medical device and software platform aimed at improving screening, early detection, and therapeutic support for cardiac disease. The company intends to expand commercially and deploy its solutions across the US, EU, Asia Pacific, and Middle East markets. It plans to use recent funding to develop new software solutions across the cardiac care continuum. Led by CEO Todor Jeliaskov, Inheart emphasizes personalized, predictive therapy to improve decision-making, efficiency of care, and safety of interventions. The announcement notes a USD11M funding round to support these initiatives. The company is based in Pessac, France. inHEART provides a cloud-based software solution that transforms preoperative medical images into a 3D digital twin of the patient’s heart to help plan procedures and assist instrument navigation. The technology is aimed at reducing procedure duration and failure rates during cardiac interventions for arrhythmias. The company plans to use new funding to accelerate commercial development in Europe, access the US market, and continue developing its AI and numerical simulations of cardiac electrical activity. Its technology has been used on more than 2,000 patients in 40 centers worldwide and has been included in the latest international expert recommendations. inHEART is a spin-off from IHU Liryc and Inria and was co-founded by Jean-Marc Peyrat, Prof. Pierre Jaïs, Maxime Sermesant and Hubert Cochet. The company is based in Pessac, France.